Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm

English

The Taylor lab seeks to understand the molecular pathophysiology of genetic alterations that drive hematologic neoplasms and how those targets might be leveraged for effective anti-cancer therapy. Currently, the major focus of the lab is on the cancer-associated alterations that occur in the nuclear export protein, XPO1.